Evaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection

DOĞAN, MUSTAFA; TOPÇU, BİROL; Karaali, RIDVAN; ERDEM, İLKNUR

doi:10.4274/vhd.galenos.2020.2020.0016

Evaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection

DOĞAN M., TOPÇU B., Karaali R., ERDEM İ.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.26, sa.2, ss.43-48, 2020 (ESCI, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 2
Basım Tarihi: 2020
Doi Numarası: 10.4274/vhd.galenos.2020.2020.0016
Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.43-48
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objectives: This study aimed to investigate the effect of treatment with direct-acting antivirals (DAAs) on the virological response and on the some parameters used to evaluate liver function in cases with chronic liver disease due to hepatitis C virus (HCV) genotype 1b.